Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFERGEN in Hospitalized 2009 H1N1 Influenza
NCT01227798Phase 2Unknown
- Sponsor
- University Health Network
- Start
- Nov 2010
- Primary completion
- Nov 2011
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in influenza comparing Infergen Arm with Placebo Arm (2 arms). Primary endpoint: Frequency of Clinically Important (moderate or severe) and serious adverse events. Status: unknown.
02
Drugs
interferon alfacon-1
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01227798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227798.